Cargando…

Correction to: Redefining mouse transgenesis with CRISPR/Cas9 genome editing technology

Detalles Bibliográficos
Autor principal:	Burgio, Gaetan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5870398/ https://www.ncbi.nlm.nih.gov/pubmed/29580259 http://dx.doi.org/10.1186/s13059-018-1424-2

Ejemplares similares

Redefining mouse transgenesis with CRISPR/Cas9 genome editing technology
por: Burgio, Gaetan
Publicado: (2018)

Harnessing CRISPR-Cas system diversity for gene editing technologies
por: McKay, Alexander, et al.
Publicado: (2021)

Inflammation conditional genome editing mediated by the CRISPR-Cas9 system
por: Yuan, Tingting, et al.
Publicado: (2023)

Bioethical issues in genome editing by CRISPR-Cas9 technology
por: AYANOĞLU, Fatma Betül, et al.
Publicado: (2020)

Correction to: CRISPR-Cas, a robust gene-editing technology in the era of modern cancer immunotherapy
por: Miri, Seyed Mohammad, et al.
Publicado: (2020)

Author Correction: Enhanced genome editing efficiency of CRISPR PLUS: Cas9 chimeric fusion proteins
por: Park, Jongjin, et al.
Publicado: (2021)

HDAC inhibitors improve CRISPR-Cas9 mediated prime editing and base editing
por: Liu, Nan, et al.
Publicado: (2022)

CRISPR/Cas9 Genome Editing for Tissue‐Specific In Vivo Targeting: Nanomaterials and Translational Perspective
por: Sahel, Deepak Kumar, et al.
Publicado: (2023)

Collateral damage and CRISPR genome editing
por: Thomas, Mark, et al.
Publicado: (2019)

Efficient Genome Editing Using CRISPR/Cas9 Technology in Chicory
por: Bernard, Guillaume, et al.
Publicado: (2019)

Applications of CRISPR-Cas9 Technology to Genome Editing in Glioblastoma Multiforme
por: Al-Sammarraie, Nadia, et al.
Publicado: (2021)

Protocols for transgenesis at a safe harbor site in the Xenopus laevis genome using CRISPR-Cas9
por: Shibata, Yuki, et al.
Publicado: (2023)

Publisher Correction: Correction of a Disease Mutation using CRISPR/Cas9-assisted Genome Editing in Japanese Black Cattle
por: Ikeda, Mitsumi, et al.
Publicado: (2018)

Author Correction: A systematic genome-wide mapping of oncogenic mutation selection during CRISPR-Cas9 genome editing
por: Sinha, Sanju, et al.
Publicado: (2022)

CRISPR/Cas9 genome editing technology in filamentous fungi: progress and perspective
por: Song, Runjie, et al.
Publicado: (2019)

Application progress of CRISPR/Cas9 genome-editing technology in edible fungi
por: Zhang, Yan, et al.
Publicado: (2023)

Correction to: CRISPR/Cas: a potential gene-editing tool in the nervous system
por: Gao, Yanxia, et al.
Publicado: (2021)

A piggyBac‐mediated transgenesis system for the temporary expression of CRISPR/Cas9 in rice
por: Nishizawa‐Yokoi, Ayako, et al.
Publicado: (2021)

Precision cancer mouse models through genome editing with CRISPR-Cas9
por: Mou, Haiwei, et al.
Publicado: (2015)

Strategies in the delivery of Cas9 ribonucleoprotein for CRISPR/Cas9 genome editing
por: Zhang, Song, et al.
Publicado: (2021)

Publisher Correction: Orthogonal Cas9-Cas9 chimeras provide a versatile platform for genome editing
por: Bolukbasi, Mehmet Fatih, et al.
Publicado: (2018)

Inducible in vivo genome editing with CRISPR/Cas9
por: Dow, Lukas E, et al.
Publicado: (2015)

Efficient Mitochondrial Genome Editing by CRISPR/Cas9
por: Jo, Areum, et al.
Publicado: (2015)

CRISPR/Cas9: Transcending the Reality of Genome Editing
por: Chira, Sergiu, et al.
Publicado: (2017)

Genome Editing in Cotton with the CRISPR/Cas9 System
por: Gao, Wei, et al.
Publicado: (2017)

Nanoparticle Delivery of CRISPR/Cas9 for Genome Editing
por: Duan, Li, et al.
Publicado: (2021)

CRISPR–Cas9 Based Bacteriophage Genome Editing
por: Zhang, Xueli, et al.
Publicado: (2022)

CRISPR/Cas9 genome editing for neurodegenerative diseases
por: Nouri Nojadeh, Jafar, et al.
Publicado: (2023)

Correction to: “Retraction of: DeepCRISTL: deep transfer learning to predict CRISPR/Cas9 functional and endogenous on-target editing efficiency”
Publicado: (2023)

Correction for Lombardi et al., “Plasmid-Based CRISPR-Cas9 Gene Editing in Multiple Candida Species”
por: Lombardi, Lisa, et al.
Publicado: (2020)

Targeted genome and epigenome editing using engineered TALE and CRISPR/Cas9 technologies
por: Gersbach, Charles A
Publicado: (2014)

CRISPR/Cas9 Genome-Editing Technology and Potential Clinical Application in Gastric Cancer
por: Almeida, Renata Sanches, et al.
Publicado: (2022)

Correction: Genome-scale CRISPR-Cas9 knockout screening in hepatocellular carcinoma with lenvatinib resistance
por: Lu, Yonggang, et al.
Publicado: (2022)

Edition of TFAM gene by CRISPR/Cas9 technology in bovine model
por: de Oliveira, Vanessa Cristina, et al.
Publicado: (2019)

Mesenchymal stromal cells improve the transplantation outcome of CRISPR-Cas9 gene-edited human HSPCs
por: Crippa, Stefania, et al.
Publicado: (2022)

Somatic genome editing with CRISPR/Cas9 generates and corrects a metabolic disease
por: Jarrett, Kelsey E., et al.
Publicado: (2017)

Editing of mouse and human immunoglobulin genes by CRISPR-Cas9 system
por: Cheong, Taek-Chin, et al.
Publicado: (2016)

Inducible Genome Editing with Conditional CRISPR/Cas9 Mice
por: Katigbak, Alexandra, et al.
Publicado: (2018)

Editing the genome of Aphanomyces invadans using CRISPR/Cas9
por: Majeed, Muhammad, et al.
Publicado: (2018)

CRISPR-Cas9-Mediated Genome Editing in Leishmania donovani
por: Zhang, Wen-Wei, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_611fdvviev867kmq8u0r55iqbt